H4 Receptor

The H4 histamine receptor is the most recently discovered (2001) and least characterized histamine receptor. It’s found primarily on immune cells — including Mast Cells themselves, eosinophils, basophils, T cells, and dendritic cells. Also found in the gut and bone marrow.

Key Functions

• Chemotaxis — attracts immune cells to sites of inflammation
• Mast cell self-activation — mast cells can activate neighboring mast cells via H4, creating a spreading wave of activation
• Itch signaling — contributes to pruritus through a pathway distinct from H1
• Chronic inflammatory regulation — involved in sustaining rather than initiating inflammation

Why It Matters

The mast cell-to-mast cell activation via H4 may explain how a localized mast cell reaction can spread. One cell degranulates → releases Histamine → nearby mast cells are activated via H4 → they degranulate → the reaction propagates. This is an area of active research and a potential future drug target.

H4 Blocker Research

No H4-selective blocker is currently approved. Several have reached clinical trials, most notably ZPL-3893888 (Ziarco/Pfizer), which showed a clean safety profile but was shelved after atopic dermatitis endpoints weren’t met — likely an indication mismatch rather than a mechanism failure. MCAS would be a better target indication since mast cells are the central pathology. See H4 Blocker Compounds for compound details and the case for repurposing.